Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future

γδ T-cells directly recognize and kill transformed cells independently of HLA-antigen presentation, which makes them a highly promising effector cell compartment for cancer immunotherapy. Novel γδ T-cell-based immunotherapies, primarily focusing on the two major γδ T-cell subtypes that infiltrate tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Saura-Esteller, José, de Jong, Milon, King, Lisa A., Ensing, Erik, Winograd, Benjamin, de Gruijl, Tanja D., Parren, Paul W. H. I., van der Vliet, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245381/
https://www.ncbi.nlm.nih.gov/pubmed/35784326
http://dx.doi.org/10.3389/fimmu.2022.915837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245381/
https://www.ncbi.nlm.nih.gov/pubmed/35784326
http://dx.doi.org/10.3389/fimmu.2022.915837

Ejemplares similares